Skip to main content

Novartis Campus opening further

Novartis Pavillon
| News

Novartis Campus opening further

24.02.2021

Novartis' 25-year anniversary also marks the next step in the ongoing opening of the campus. The Switzerland Innovation Park Basel Area is the first major external organization to already have offices on the Novartis Campus.

Novartis Pavillon

The biotech and pharma group Novartis has announced that they are opening their campus further for the public. In a first phase, starting this year, Novartis opens the premises for startups, incubators, institutes, companies and partners. With this step, the company wants to strengthen collaboration between leading and emerging players in the fields of research, development and technology.

The first partner already on the campus is the Switzerland Innovation Park Basel Area that operates offices on the campus. Opened in mid-2020, the site of Switzerland Innovation Park Basel Area, which is run by Basel Area Business & Innovation, supports startups and established companies from the fields of digital health and personalized medicine. The objective is to establish a closeness between startups and the scientists from Novartis.

The second step will start late in 2022, when the Novartis Campus will be opened to the public during working hours. The Novartis Pavilion, which is currently under construction, will be a first visible milestone for the opening.

“By inviting the public to engage in dialogue in the Novartis Pavillon, we are strengthening our commitment and interaction with society as a whole and especially with the local community. We want to create transparency by encouraging exchanges and learning from each other,” said Jörg Reinhardt, Chairman of the Board of Directors. Novartis is confident the Campus opening will boost Basel as a business location and Switzerland in general.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Roche investing an additional 1.2 billion Swiss francs in Basel

Roche will be putting an additional 1.2 billion Swiss francs towards the renovation of its site in Basel. This investment...
Read More

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023

On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New Ideas came to its conclusion....
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

How to access the U.S. market with your medical device

In one of our latest Venture Mentoring events by Basel Are Business & Innovation, we invited Nila-Pia Rähle to speak...
Read More

Paradigm shift in pain management

Pain is a crucial sensation for survival, but it can also drive us to depression and long-term suffering if not...
Read More

Do you have a question? We'd like to hear from you.